XML 39 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock Plans
6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Plans
Note 11. Stock Plans

Stock Options:
Stock option activity is reflected below:
 
Shares Subject
to Option
 
Weighted-
Average
Exercise or
Grant Price
Per Share
 
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Balance at January 1, 2018
48,434,655

 
$29.92
 
5 years
 
$
626
 million
Annual grant to eligible employees
5,666,530

 
43.51
 
 
 
 
Additional options issued
82,720

 
40.82
 
 
 
 
Total options granted
5,749,250

 
43.47
 
 
 
 
Options exercised (1)
(4,541,932
)
 
25.60
 
 
 
$
81
 million
Options canceled
(541,994
)
 
38.39
 
 
 
 
Balance at June 30, 2018
49,099,979

 
31.81
 
6 years
 
$
478
 million

(1)
Cash received from options exercised was $31 million in the three months and $116 million in the six months ended June 30, 2018. The actual tax benefit realized and recorded in the provision for income taxes for the tax deductions from the option exercises totaled $1 million in the three months and $9 million in the six months ended June 30, 2018.

Performance Share Units and Other Stock-Based Awards:
Our performance share unit, deferred stock unit and historically granted restricted stock activity is reflected below:
 
Number
of Shares
 
Grant Date
 
Weighted-Average
Fair Value
Per Share (3)
 
Weighted-Average
Aggregate
Fair Value (3)
Balance at January 1, 2018
7,669,705

 
 
 
$39.74
 
 
Annual grant to eligible employees:
 
 
Feb 22, 2018
 
 
 
 
Performance share units
1,048,770

 
 
 
51.23
 
 
Deferred stock units
788,310

 
 
 
43.51
 
 
Additional shares granted (1)
306,426

 
Various
 
40.97
 
 
Total shares granted
2,143,506

 
 
 
46.92
 
$
101
 million
Vested (2)
(2,162,663
)
 
 
 
38.33
 
$
83
 million
Forfeited (2)
(352,565
)
 
 
 
40.10
 
 
Balance at June 30, 2018
7,297,983

 
 
 
42.25
 
 

(1)
Includes performance share units and deferred stock units.
(2)
Includes performance share units, deferred stock units and historically granted restricted stock. The actual tax benefit realized and recorded in the provision for income taxes for the tax deductions from the shares vested totaled less than $1 million in the three months and $4 million in the six months ended June 30, 2018.
(3)
The grant date fair value of performance share units is determined based on the Monte Carlo simulation model for the market-based total shareholder return component and the closing market price of the Company’s stock on the grant date for performance-based components. The Monte Carlo simulation model incorporates the probability of achieving the total shareholder return market condition. Compensation expense is recognized using the grant date fair values regardless of whether the market condition is achieved, so long as the requisite service has been provided.

Share Repurchase Program:
Between 2013 and 2017, our Board of Directors authorized the repurchase of a total of $13.7 billion of our Common Stock through December 31, 2018. On January 31, 2018, our Finance Committee, with authorization delegated from our Board of Directors, approved an increase of $6.0 billion in the share repurchase program, raising the authorization to $19.7 billion of Common Stock repurchases, and extended the program through December 31, 2020. Repurchases under the program are determined by management and are wholly discretionary. Prior to January 1, 2018, we had repurchased $13.0 billion of Common Stock pursuant to this authorization. During the six months ended June 30, 2018, we repurchased approximately 27.6 million shares of Common Stock at an average cost of $41.65 per share, or an aggregate cost of approximately $1.2 billion, all of which was paid during the period. All share repurchases were funded through available cash and commercial paper issuances. As of June 30, 2018, we have $5.5 billion in remaining share repurchase capacity.